A Novel Cause of Familial Hypercholesterolemia: PCSK9 Gene Duplication

被引：3
|
作者：
Paquette, Martine [1 ]
Baass, Alexis [1 ,2 ,3 ]
机构：
[1] Montreal Clin Res Inst, Lipids Nutr & Cardiovasc Prevent Clin, 110 Ave Pins Ouest, Montreal, PQ H2W 1R7, Canada
[2] McGill Univ, Div Expt Med, Dept Med, Montreal, PQ, Canada
[3] McGill Univ, Div Med Biochem, Dept Med, Montreal, PQ, Canada
来源：
CANADIAN JOURNAL OF CARDIOLOGY | 2018年 / 34卷 / 10期
关键词：
AUTOSOMAL-DOMINANT HYPERCHOLESTEROLEMIA; DENSITY-LIPOPROTEIN RECEPTOR; MUTATIONS;
D O I：
10.1016/j.cjca.2018.08.027
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1259 / 1260
页数：2
相关论文
共 50 条
  • [21] Targeting PCSK9 for Hypercholesterolemia
    Norata, Giuseppe Danilo
    Tibolla, Gianpaolo
    Catapano, Alberico Luigi
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 54, 2014, 54 : 273 - 293
  • [22] Inhibition of PCSK9 as a Novel Strategy for the Treatment of Hypercholesterolemia
    Lopez, Dayami
    DRUG NEWS & PERSPECTIVES, 2008, 21 (06) : 323 - 330
  • [23] Targeted Next-Generation Sequencing of PCSK9 Gene in Patients With Familial Hypercholesterolemia in Russia
    Shakhtshneider, E. V.
    Makarenkova, K. V.
    Astrakova, K. S.
    Ivanoshchuk, D. E.
    Orlov, P. S.
    Ragino, Yu. I.
    Voevoda, M. I.
    KARDIOLOGIYA, 2017, 57 (06) : 46 - 51
  • [24] PCSK9 Mutations in Familial Hypercholesterolemia: from a Groundbreaking Discovery to Anti-PCSK9 Therapies
    El Khoury, Petra
    Elbitar, Sandy
    Ghaleb, Youmna
    Abou Khalil, Yara
    Varret, Mathilde
    Boileau, Catherine
    Abifadel, Marianne
    CURRENT ATHEROSCLEROSIS REPORTS, 2017, 19 (12)
  • [25] PCSK9 Mutations in Familial Hypercholesterolemia: from a Groundbreaking Discovery to Anti-PCSK9 Therapies
    Petra El Khoury
    Sandy Elbitar
    Youmna Ghaleb
    Yara Abou Khalil
    Mathilde Varret
    Catherine Boileau
    Marianne Abifadel
    Current Atherosclerosis Reports, 2017, 19
  • [26] A Decision Aid for the Use of PCSK9 Inhibitors in Patients With Familial Hypercholesterolemia
    Farwati, Medhat
    Shaw, Kevin
    Hargraves, Ian G.
    Montori, Victor M.
    Kullo, Iftikhar J.
    CIRCULATION, 2018, 138
  • [27] PCSK9 Inhibitors for Homozygous Familial Hypercholesterolemia Useful But Seldom Sufficient
    Thompson, Gilbert R.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 76 (02) : 143 - 145
  • [28] LIPOPROTEIN(A) IN FAMILIAL HYPERCHOLESTEROLEMIA WITH PCSK9 GAIN-OF-FUNCTION MUTATIONS
    Tada, Hayato
    Kawashiri, Masa-Aki
    Nohara, Atsushi
    Inazu, Akihiro
    Mabuchi, Hiroshi
    Yamagishi, Masakazu
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 1896 - 1896
  • [29] NEW GAIN OF FUNCTIONS MUTATIONS IN PCSK9 AND THEIR IMPACT IN FAMILIAL HYPERCHOLESTEROLEMIA
    AbiFadel, M.
    Rabes, J. -P.
    Guerin, M.
    Carreau, V.
    Carrie, A.
    Varret, M.
    Samson-Bouma, M. -E.
    Tosolini, L.
    Erlich, D.
    Couvert, P.
    Bonnefont-Rousselot, D.
    Bruckert, E.
    Prat, A.
    Seidah, N.
    Boileau, C.
    ATHEROSCLEROSIS SUPPLEMENTS, 2011, 12 (01) : 10 - 10
  • [30] CHARACTERIZATION OF THE EFFECTS OF FAMILIAL HYPERCHOLESTEROLEMIA MUTATIONS IN LDLR ON PCSK9 BINDING
    Deng, Shijun
    Alabi, Adekunle
    Zhang, Dawei
    ATHEROSCLEROSIS SUPPLEMENTS, 2018, 32 : 55 - 55
12345